Skip to main content

Immatics N.V.

IMTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001809196

In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Immatics N.V. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of IMTX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders6874+6
Shares41.0M43.3M+2.30M (+5.6%)
Value$472.7M$501.0M+$28.3M (+6.0%)

New holders (11)

Institutions that held Immatics N.V. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to IMTX in Q3 2023
InstitutionSharesValue% of portfolio
Ameriprise Financial Inc332,243$3.85M0.00%
Adage Capital Partners GP, L.L.C.326,500$3.78M0.01%
Zimmer Partners, LP175,000$2.03M0.05%
Walleye Capital LLC113,847$1.32M0.02%
Moore Capital Management, LP50,400$583.6K0.02%
Trexquant Investment LP42,972$497.6K0.01%
Jump Financial, LLC40,470$468.6K0.02%
Walleye Trading LLC16,347$189.3K0.00%
BIT Capital GmbH5,143$59.6K0.01%
Group One Trading, L.P.2,188$25.3K0.00%
Jefferies Financial Group Inc.2,158$25.0K0.00%

Sold out (5)

Institutions that held Immatics N.V. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of IMTX in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Schonfeld Strategic Advisors LLC90,871$1.05M
Silverarc Capital Management, LLC30,715$354.5K
Cambridge Investment Research Advisors, Inc.14,717$170.0K
Sunbelt Securities, Inc.500$5.77K
Tower Research Capital LLC (TRC)66$762